Kenneth Harper
Family Medicine · Decatur, GANPI 1871669994
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,254 and has fallen 88.0% since, to $150 in 2024.
Across 239 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$714
- Novo Nordisk$706
- Sanofi-aventis U.S. LLC$410
- AbbVie$385
- Lilly USA, LLC$350
- Boehringer Ingelheim$226
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,124100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $714 |
| Novo Nordisk | 52 | $706 |
| Sanofi-aventis U.S. LLC | 22 | $410 |
| AbbVie(2 entities) | 21 | $385 |
| Lilly USA, LLC | 22 | $350 |
| Boehringer Ingelheim | 13 | $226 |
| Merck | 13 | $179 |
| Bard Peripheral Vascular, Inc. | 1 | $150 |
| Novartis | 8 | $143 |
| Merz North America, Inc. | 1 | $123 |
| Bayer | 7 | $121 |
| Pfizer | 5 | $75 |
| Amarin Pharma, Inc. | 4 | $74 |
| Arbor Pharmaceuticals, Inc. | 5 | $66 |
| Tactile Systems Technology Inc | 1 | $65 |
| Johnson & Johnson | 3 | $55 |
| Dexcom, Inc. | 3 | $49 |
| Amgen | 2 | $42 |
| Boston Scientific | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Dynavax Technologies Corporation | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Qiagen, LLC | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$150
- ASCLERA$123
How this compares
$4,124 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Decatur
- Regina WangDecatur$25K
- Mohammed AliDecatur$23K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.